Current Evaluation of Amenorrhea

    October 2006 in “ Fertility and Sterility ”
    Image of study
    TLDR The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.
    The 2006 document by the Practice Committee of the American Society for Reproductive Medicine provides an overview of the evaluation of amenorrhea, distinguishing between primary and secondary amenorrhea and noting a prevalence of 3% to 4% for non-pregnancy, non-lactation, and non-menopause related cases. It identifies polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure as the most common causes. The evaluation process includes a history and physical examination, along with measurement of FSH, TSH, and prolactin levels. The document highlights the need for a karyotype in women under 30 with ovarian failure and the consideration of autoimmune and genetic factors in premature ovarian failure. It also discusses the differentiation between hypothalamic amenorrhea and PCOS, the risk of osteoporosis, and the potential need for estrogen-progestin therapy or ovulation induction. Screening for type 2 diabetes in women with PCOS is recommended, emphasizing the importance of identifying the underlying cause of amenorrhea for appropriate treatment.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 12 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 2 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community C’est terrible - at my wits end

      in Female  443 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  56 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 5 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

    Related Research

    1 / 1 results